CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Consulting and advisory fees	$ 39,650	$ 177,726	$ 193,995	$ 904,187
Related party consulting fees	89,500	84,000	264,000	296,000
General and administrative expenses	67,761	48,381	189,151	207,997
Professional fees	87,981	62,445	212,986	231,073
Advertising and marketing expense	548	14,688	4,406	22,987
Research and development expense	67,524	0	147,259	0
Total operating expenses	352,964	387,240	1,011,797	1,662,244
Loss from operations	(352,964)	(387,240)	(1,011,797)	(1,662,244)
Amortization of debt discount	(2,569)	0	(2,569)	(461,842)
Financing fees	0	(20,600)	0	(20,600)
Interest expense	(28,563)	0	(895,891)	0
Change in fair value of convertible bridge loans	0	(817)	(2,448)	(817)
Gain (loss) from Ebenberg JV	0	18,919	0	(96,131)
Loss on extinguishment of debt	0	0	(20,298)	(4,259,987)
Total other (expense) income	(31,132)	(2,498)	(921,206)	(4,839,377)
Net loss	(384,096)	(389,738)	(1,933,003)	(6,501,621)
Less net loss attributable to noncontrolling interest	(7,769)	(7,229)	(23,403)	(21,961)
Net loss attributable to common stockholders	$ (376,327)	$ (382,509)	$ (1,909,600)	$ (6,479,660)
Net loss per common share - basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.02)
Weighted average number of common shares outstanding - basic and diluted	449,266,866	377,710,922	422,070,403	372,820,541